Crossmark

Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study

Published Online: 2018-06-10

Published Print: 2018-12

Authors

Calabrese, Joseph R.

Jin, Na

Johnson, Brian

Such, Pedro

Baker, Ross A.

Madera, Jessica

Hertel, Peter

Ottinger, Jocelyn

Amatniek, Joan

Kawasaki, Hiroaki
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct01710709 at ClinicalTrials.gov

Documents that mention this clinical trial

Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study
https://doi.org/10.1186/s40345-018-0122-z
Funding

Funding for this research was provided by:

Otsuka Pharmaceutical Development & Commercialization, Inc.

H. Lundbeck A/S
License Information

Text and Data Mining valid from 2018-06-10

Version of Record valid from 2018-06-10
More Information

Article History

Received: 24 January 2018

Accepted: 21 April 2018

First Online: 10 June 2018

Document is current